Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
Labial agglutination (LA) can affect prepubertal or postmenopausal women. LA commonly affects prepubertal girls, but the rate at which LA affects postmenopausal women is unknown, with only a few documented case reports. Symptoms of LA include vulvovaginal pain, dysuria, dyspareunia, and urinary incontinence/urinary symptoms. First-line treatment includes low dose estrogen cream and high dose topical steroid cream. If the creams fail, surgical lysis can be performed. The commonality between these age groups is chronic inflammation and low estrogen. It is important to keep in mind, especially in postmenopausal women, that LA can lead to urinary symptom side effects.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807131 | PMC |
http://dx.doi.org/10.1016/j.eucr.2021.101565 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!